Projects funded by the NCN
Does myoinositol trispyrophosphate protect against the developement of the right ventricular heart failure in pulmonary artery banding model in rats. Implications for pulmonary hypertension treatment.
2022/45/N/NZ5/03399
Keywords:
pulmonary hypertension right ventricular heart failure PAB
Descriptors:
- NZ5_7: Human disease treatment
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Centrum Medyczne Kształcenia Podyplomowego
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 21 - announced on 2022-03-28
Amount awarded: 139 920 PLN
Project start date (Y-m-d): 2023-01-23
Project end date (Y-m-d): 2025-01-22
Project duration:: 24 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.